0001209191-15-049211.txt : 20150602 0001209191-15-049211.hdr.sgml : 20150602 20150602200804 ACCESSION NUMBER: 0001209191-15-049211 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150529 FILED AS OF DATE: 20150602 DATE AS OF CHANGE: 20150602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUTTER MARTIN P CENTRAL INDEX KEY: 0001017832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 15908499 MAIL ADDRESS: STREET 1: 2170 BUCKTHORNE PLACE STREET 2: SUITE 170 CITY: THE WOODLAND STATE: TX ZIP: 77380 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-29 0 0000815094 ABIOMED INC ABMD 0001017832 SUTTER MARTIN P 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380 1 0 0 0 Common Stock, $0.01 par value 2015-05-19 4 J 0 24747 67.74 A 150369 D Common Stock, $0.01 par value 2015-05-29 4 P 0 7500 60.17 A 157869 D Common Stock, $0.01 par value 946818 I By Essex Woodlands Health Ventures Fund VI, L.P. Common Stock, $0.01 par value 1203182 I By Essex Woodlands Health Ventures Fund VII, L.P. Stock option (right to buy) 13.91 2009-05-20 2018-05-20 Common Stock 25000 25000 D Stock option (right to buy) 18.63 2009-08-12 2018-08-13 Common Stock 12000 12000 D Stock option (right to buy) 7.67 2010-08-11 2019-08-12 Common Stock 12000 12000 D Stock option (right to buy) 9.99 2011-08-10 2020-08-11 Common Stock 12000 12000 D Mr. Sutter received 24,747 shares of Common Stock as a payment-in-kind distribution from Essex Woodlands Health Ventures Fund VII, L.P. ("Fund VII") to its general partner and limited partners of an aggregate payment-in-kind distribution of 1,000,000 shares of Common Stock. On May 29, 2015, Mr. Sutter purchased an aggregate of 7,500 shares of Common Stock of the Issuer in multiple open market transactions, with prices ranging from $59.80 to $60.50. These securities are held by Essex Woodlands Health Ventures Fund VI, L.P. ("Fund VI"). Mr. Sutter is a managing director of Essex Woodlands Health Ventures VI, L.P., the general partner that manages Fund VI. As managing director, Mr. Sutter shares voting and investment powers for Fund VI. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein. On May 19, 2015, Fund VII made a payment-in-kind distribution of 1,000,000 shares of Issuer's Common Stock to its partners pro-rata based on their respective interests in Fund VII rather than selling the shares and distributing the proceeds. These securities are held by Fund VII. Mr. Sutter is a managing director of Essex Woodlands Health Ventures VII, L.P., the general partner that manages Fund VII. As managing director, Mr. Sutter shares voting and investment powers for Fund VII. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein. Grant to reporting person to buy shares of Common Stock of Issuer under ABIOMED, Inc. 2000 Stock Incentive Plan. These options become exercisable in annual 20% increments commencing on the date set forth in Table II, Column 6. Grant to reporting person of option to buy shares of Common Stock of Issuer set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. /s/ Martin P. Sutter 2015-06-02